Abstract:The results of surgery compare well with other reported series. 5FU did not demonstrate significant benefit in terms of intraocular pressure lowering beyond 2 months postoperatively. Early postoperative hypotony should be avoided. The gender difference in intraocular pressure results has not previously been reported and deserves further investigation.
“…The mean reduction in IOP from 32.2 mm Hg (median ¼ 30.5; SD ¼ 11.4) in the preoperative period to 17.8 mm Hg (median ¼ 17.0; SD ¼ 5.8) at a year follow-up compares with report from other previous studies. 4,[17][18][19] There was no significant difference between the 5-FU and the non-5-FU groups at a year follow-up in term of their mean IOP (P ¼ 0.6). The survival curve between the two groups also failed to demonstrate any added advantage to the use of antimetabolites.…”
Section: Discussionmentioning
confidence: 99%
“…Shallow anterior chamber ranked highest in the list of early post-operative complications and is similar to what had being reported in some other previous studies. 4,12,15,[20][21] There was no clinically documented case of choroidal effusion/detachment, the incidence of which is very low among blacks compared to Caucasians. This study showed no significant correlation between the use of 5-FU and the presence of postoperative shallow anterior chamber.…”
Section: Discussionmentioning
confidence: 99%
“…The difference was not statistically significant (log rank P ¼ 0.136; Breslow P ¼ 0.67). There has been conflicting report concerning the complications and long-term outcome of trabeculectomy in term of IOP control and the intraoperative use of antimetabolite (5-FU) Kabiru et al 4 and Leyland et al 20 found no added advantage in the use of antimetabolite. However, some other studies 21,22 reported a significant benefit with the use of intraoperative use of 5-FU.…”
Section: Discussionmentioning
confidence: 99%
“…1 It continues to outperform both medical and laser treatment in this regard, 2,3 especially in Africans where availability of and compliance with topical therapy are limited. 4 Also, trabeculectomy has been reported to be more beneficial in Africans in term of IOP lowering effect and slowing down of field loss. [5][6][7] The goal of the surgery is to establish a permanent flow of aqueous from the anterior chamber to the subconjuctival space thereby lowering the IOP.…”
Section: Introductionmentioning
confidence: 99%
“…Studies have reported various types of complications following trabeculectomy with incidence differing from one study to another 4,[12][13][14][15][16] depending on the duration of follow-up, the study population and the surgical techniques such as the use of antimetabolite and releasable sutures. Some of these complications are self-limiting while some adversely affect the overall success of the procedure.…”
Objective To describe the post-operative complications reported in patients who had trabeculectomy with and without antimetabolite in UCH, Ibadan between 1999 and 2003 and the success rate achieved in term of the post-operative intraocular pressure (IOP). Methods A retrospective study of the records of glaucoma patients who had trabeculectomy between 1999 and 2003 and had follow-up in UCH Ibadan eye clinic for a minimum of 1 year was carried out. Results Seventy-six out of 171 eyes that had trabeculectomy during the period were reviewed. Mean age of patients was 49.4 years. The mean preoperative IOP was 31.8 mm Hg. Success rate of 79.4% was achieved in term of IOP control at a year of follow-up. The most frequent early post-operative complication was shallow AC (13 eyes; 17.1%) while late complication was elevated IOP (21 eyes; 27.6%). Others were encapsulated bleb 7.9% and hyphema 3.9%. There was no significant difference in the complication rate in those who had intraoperative antimetabolite (5-fluorouracil) when compared with those operated without antimetabolite. Conclusion Guarded filtration surgery is effective in controlling IOP. Most of the complications noted were transient and not visually threatening.
“…The mean reduction in IOP from 32.2 mm Hg (median ¼ 30.5; SD ¼ 11.4) in the preoperative period to 17.8 mm Hg (median ¼ 17.0; SD ¼ 5.8) at a year follow-up compares with report from other previous studies. 4,[17][18][19] There was no significant difference between the 5-FU and the non-5-FU groups at a year follow-up in term of their mean IOP (P ¼ 0.6). The survival curve between the two groups also failed to demonstrate any added advantage to the use of antimetabolites.…”
Section: Discussionmentioning
confidence: 99%
“…Shallow anterior chamber ranked highest in the list of early post-operative complications and is similar to what had being reported in some other previous studies. 4,12,15,[20][21] There was no clinically documented case of choroidal effusion/detachment, the incidence of which is very low among blacks compared to Caucasians. This study showed no significant correlation between the use of 5-FU and the presence of postoperative shallow anterior chamber.…”
Section: Discussionmentioning
confidence: 99%
“…The difference was not statistically significant (log rank P ¼ 0.136; Breslow P ¼ 0.67). There has been conflicting report concerning the complications and long-term outcome of trabeculectomy in term of IOP control and the intraoperative use of antimetabolite (5-FU) Kabiru et al 4 and Leyland et al 20 found no added advantage in the use of antimetabolite. However, some other studies 21,22 reported a significant benefit with the use of intraoperative use of 5-FU.…”
Section: Discussionmentioning
confidence: 99%
“…1 It continues to outperform both medical and laser treatment in this regard, 2,3 especially in Africans where availability of and compliance with topical therapy are limited. 4 Also, trabeculectomy has been reported to be more beneficial in Africans in term of IOP lowering effect and slowing down of field loss. [5][6][7] The goal of the surgery is to establish a permanent flow of aqueous from the anterior chamber to the subconjuctival space thereby lowering the IOP.…”
Section: Introductionmentioning
confidence: 99%
“…Studies have reported various types of complications following trabeculectomy with incidence differing from one study to another 4,[12][13][14][15][16] depending on the duration of follow-up, the study population and the surgical techniques such as the use of antimetabolite and releasable sutures. Some of these complications are self-limiting while some adversely affect the overall success of the procedure.…”
Objective To describe the post-operative complications reported in patients who had trabeculectomy with and without antimetabolite in UCH, Ibadan between 1999 and 2003 and the success rate achieved in term of the post-operative intraocular pressure (IOP). Methods A retrospective study of the records of glaucoma patients who had trabeculectomy between 1999 and 2003 and had follow-up in UCH Ibadan eye clinic for a minimum of 1 year was carried out. Results Seventy-six out of 171 eyes that had trabeculectomy during the period were reviewed. Mean age of patients was 49.4 years. The mean preoperative IOP was 31.8 mm Hg. Success rate of 79.4% was achieved in term of IOP control at a year of follow-up. The most frequent early post-operative complication was shallow AC (13 eyes; 17.1%) while late complication was elevated IOP (21 eyes; 27.6%). Others were encapsulated bleb 7.9% and hyphema 3.9%. There was no significant difference in the complication rate in those who had intraoperative antimetabolite (5-fluorouracil) when compared with those operated without antimetabolite. Conclusion Guarded filtration surgery is effective in controlling IOP. Most of the complications noted were transient and not visually threatening.
Low-dose TSCPC caused a significant IOP lowering for up to 2 weeks (15 mmHg less from baseline) in most patients. After 3 months, this effect was stable in 50% of patients; in the other half, IOP nearly returned back to baseline.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.